Latest debt-to-equity ratio
enGene Therapeutics Debt-to-equity ratio
Direct answer
enGene Therapeutics's debt-to-equity ratio is 14.45%.
The verified market snapshot reports 14.45%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 5, 2026.
Get free enGene Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 14.45%
Explore related company data
View enGene Therapeutics's market capitalizationView enGene Therapeutics's price-to-book ratioView enGene Therapeutics's return on equityView enGene Therapeutics's dividend yieldView enGene Therapeutics's 52-week price rangeView enGene Therapeutics's profit marginView all enGene Therapeutics key metricsReturn to enGene Therapeutics profile